Literature DB >> 11681407

AC133 expression in human stem cells.

M Bhatia1.   

Abstract

Expression of cell surface markers on human hematopoietic cells has provided a method for characterizing subsets of cells with distinct biological functions. This is largely due to the ability to separate highly purified subpopulations of cells for comparative analysis. Relationships between the cell surface phenotype of these subpopulations and their proliferative and differentiative capacity have been instrumental in defining the hierarchical organization of cells comprising the human hematopoietic system. The identification and isolation of human hematopoietic cells expressing AC133, combined with use of in vitro and in vivo assays, has provided novel insights into the hematopoietic progenitor and stem cell compartment in the human. More recent studies have offered evidence that AC133 expression is not limited to primitive blood cells, but also defines unique cell populations in non-hematopoietic tissues. These findings will be reviewed here in the context of human hematopoiesis and the potential role and utility of AC133 expression in the human.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681407     DOI: 10.1038/sj.leu.2402255

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  33 in total

1.  CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope.

Authors:  Anthony B Mak; Kim M Blakely; Rashida A Williams; Pier-Andrée Penttilä; Andrey I Shukalyuk; Khan T Osman; Dahlia Kasimer; Troy Ketela; Jason Moffat
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Authors:  Matteo Brioschi; John Fischer; Roberto Cairoli; Stefano Rossetti; Laura Pezzetti; Michele Nichelatti; Mauro Turrini; Francesca Corlazzoli; Barbara Scarpati; Enrica Morra; Nicoletta Sacchi; Alessandro Beghini
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

3.  CD133 marks a stem cell population that drives human primary myelofibrosis.

Authors:  Ioanna Triviai; Thomas Stübig; Birte Niebuhr; Kais Hussein; Asterios Tsiftsoglou; Boris Fehse; Carol Stocking; Nicolaus Kröger
Journal:  Haematologica       Date:  2015-02-27       Impact factor: 9.941

4.  Isolation of renal progenitor cells from adult human kidney.

Authors:  Benedetta Bussolati; Stefania Bruno; Cristina Grange; Stefano Buttiglieri; Maria Chiara Deregibus; Dario Cantino; Giovanni Camussi
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.

Authors:  X-H Yao; Y-F Ping; J-H Chen; C-P Xu; D-L Chen; R Zhang; J M Wang; X-W Bian
Journal:  J Pathol       Date:  2008-08       Impact factor: 7.996

6.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

7.  CD34+ and CD133+ Primitive Stem Cell Expression in Peripheral Blood: Considering Gender, Age, and Smoking.

Authors:  Heike Reichelt; Dagmar Barz; Hansjörg Thude
Journal:  Transfus Med Hemother       Date:  2009-03-06       Impact factor: 3.747

8.  Proteome of human colon cancer stem cells: a comparative analysis.

Authors:  Jian Zou; Xiao-Feng Yu; Zhi-Jun Bao; Jie Dong
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

9.  Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.

Authors:  C P McGuckin; N Forraz; R Pettengell; A Thompson
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

Review 10.  Cardiac repair with adult bone marrow-derived cells: the clinical evidence.

Authors:  Buddhadeb Dawn; Ahmed Abdel-Latif; Santosh K Sanganalmath; Michael P Flaherty; Ewa K Zuba-Surma
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.